Results 11 to 20 of about 33,119 (158)

The Distribution of opiates, cocaine and their metabolites in skeletal muscle tissue and vitreous humour as an aid to post-mortem toxicological interpretation. [PDF]

open access: yes
Post-mortem blood drug concentrations vary greatly and as a consequence of post-mortem change and redistribution may not reflect the concentration at the time of death.
Rees, Kelly-Ann
core   +9 more sources

Inflammatory and angiogenic protein detection in the human vitreous : cytometric bead assay [PDF]

open access: yes, 2011
Introduction. To evaluate clinical feasibility and reproducibility of cytometric bead assay (CBA) in nondiluted vitreous samples of patients with age-related macular degeneration (ARMD), diabetic macular edema (DME), and central retinal vein occlusion ...
Koch, Frank H.   +2 more
core   +1 more source

Hyalocytes in tissue engineering - First steps towards a cell-based vitreous substitute [PDF]

open access: yes, 2007
The vitreous body represents the main compartment of the eye. This unique tissue is free of cells in its centre, however, in the cortex of the vitreous body and in the vitreous base, there are a sparse number of cells, designated as hyalocytes.
Sommer, Florian
core   +1 more source

Correlation of inflammatory and proangiogenic cytokines from undiluted vitreous samples with spectral domain OCT scans, in untreated branch retinal vein occlusion [PDF]

open access: yes, 2013
Purpose: To assess the levels of inflammatory and angiogenic cytokines in undiluted vitreous from treatment-naïve patients with macular edema secondary to nonischemic branch retinal vein occlusion (BRVO), with flow cytometric bead array (CBA) and to ...
Michaelis, Martin   +8 more
core   +1 more source

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage [PDF]

open access: yes, 2020
Background: To evaluate the safety and efficacy of intravitreal ziv-aflibercept (IVZ) in the management of vitreous hemorrhage (VH) in eyes with previously lasered proliferative diabetic retinopathy (PDR).
El Jawhari, Khalil M.   +8 more
core   +1 more source

Central retinal artery occlusion secondary to presumed traumatic carotid artery dissection in a healthy child

open access: yesInternational Journal of Retina and Vitreous, 2022
Purpose To describe a rare case of a 13 years-old healthy child that presented CRAO secondary to carotid artery dissection, which occurred after a neck rotation movement. Methods Case report with prospective literature review.
Thiago José Muniz Machado Mazzeo   +4 more
doaj   +1 more source

Internal limiting membrane detachment in acute central retinal artery occlusion: a novel prognostic sign seen on OCT

open access: yesInternational Journal of Retina and Vitreous, 2021
Background To present a series of acute central retinal artery occlusion (CRAO) cases showing internal limiting membrane detachment (ILMD) on optical coherence tomography (OCT) and to describe the possible etiopathogenesis and outcomes associated with it.
Ramesh Venkatesh   +7 more
doaj   +1 more source

Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity

open access: yesInternational Journal of Retina and Vitreous, 2022
Background To report spectral domain optical coherence tomography (SDOCT) imaging findings in type 2 macular telangiectasia (MacTel) and correlate them with clinical stages and visual acuity.
Ramesh Venkatesh   +6 more
doaj   +1 more source

Primary vitreous cysts

open access: yes, 2020
Objective: To report two cases of vitreous cysts with discussion of their pathophysiology and management.Methods: Clinical examination with fundus photography, ultrasound and optical coherence tomography.
Thoma, D   +13 more
core   +1 more source

Treat and extend regimen with aflibercept for chronic central retinal vein occlusions: 2 year results of the NEWTON study

open access: yesInternational Journal of Retina and Vitreous, 2019
Background To determine whether aflibercept (Eylea; Regeneron Pharmaceuticals, Inc., Tarrytown, NY) could continue to extend the macular edema free interval in patients on a treat and extend (TAE) with non-ischemic central retinal vein occlusions (CRVOs)
Rahul N. Khurana   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy